ADPT - Adaptive Biotechnologies Corp - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ADPT is currently covered by 5 analysts with an average price target of $14.65. This is a potential upside of $2.09 (16.64%) from yesterday's end of day stock price of $12.56.

Adaptive Biotechnologies Corp's activity chart (see below) currently has 34 price targets and 42 ratings on display. The stock rating distribution of ADPT is 70.59% BUY and 29.41% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 72.69% with an average time for these price targets to be met of 133.25 days.

Highest price target for ADPT is $15, Lowest price target is $9, average price target is $9.8.

Most recent stock forecast was given by DAVID WESTENBERG from PIPER SANDLER on 06-Aug-2025. First documented stock forecast 22-Jul-2019.

Currently out of the existing stock ratings of ADPT, 12 are a BUY (70.59%), 5 are a HOLD (29.41%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$15

$1.96 (15.03%)

$13

13 days ago
(06-Aug-2025)

11/14 (78.57%)

$3.31 (28.31%)

240

Hold

$9

$-4.04 (-30.98%)

$10

3 months 14 days ago
(05-May-2025)

4/7 (57.14%)

$-1.03 (-10.27%)

327

Buy

$10

$-3.04 (-23.31%)

$9

3 months 17 days ago
(02-May-2025)

5/6 (83.33%)

$0.16 (1.63%)

96

Buy

$9

$-4.04 (-30.98%)

$8

8 months 1 days ago
(18-Dec-2024)

5/8 (62.5%)

$3.03 (50.75%)

108

Buy

$6

$-7.04 (-53.99%)

$8

1 years 17 days ago
(02-Aug-2024)

2/2 (100%)

$1.7 (39.53%)

222

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ADPT (Adaptive Biotechnologies Corp) average time for price targets to be met?

On average it took 133.25 days on average for the stock forecasts to be realized with a an average price target met ratio 72.69

Which analyst has the current highest performing score on ADPT (Adaptive Biotechnologies Corp) with a proven track record?

MARK MASSARO

Which analyst has the current lower performing score on ADPT (Adaptive Biotechnologies Corp) with a proven track record?

SUNG JI NAM

Which analyst has the most public recommendations on ADPT (Adaptive Biotechnologies Corp)?

Mark Massaro works at BTIG and has 3 price targets and 2 ratings on ADPT

Which analyst is the currently most bullish on ADPT (Adaptive Biotechnologies Corp)?

Sung Ji Nam with highest potential upside - $9.55

Which analyst is the currently most reserved on ADPT (Adaptive Biotechnologies Corp)?

Rachel Vatnsdal with lowest potential downside - -$7.04

Adaptive Biotechnologies Corp in the News

Adaptive Biotechnologies Second Quarter 2025 Earnings: Beats Expectations

Explore Adaptive Biotechnologies’s Fair Values from the Community and select yours Adaptive Biotechnologies (NASDAQ:ADPT) Second Quarter 2025 Results Key Financial Results Revenue: US$58.9m (up 36% from 2Q 2024). Net loss: US$25.6m (loss narrowed by 45% from 2Q 2024). US$0.17 loss per share (improved from US$0.31 loss in 2Q 2024). This technology could replace computers: discover...

Adaptive Biotechnologies (ADPT) is a Great Momentum Stock: Should You Buy?

Momentum investing revolves around the idea of following a stock’s recent trend in either direction. In the ‘long’ context, investors will be essentially be “buying high, but hoping to sell even higher.” With this methodology, taking advantage of trends in a stock’s price is key; once a stock establishes a course, it is more than...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?